Exact Sciences Announces Pricing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Grand Canyon Education places CFO on leave amid stock trade probe
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- Funds sell $44bn in semiconductors on AI concerns
Exact Sciences (EXAS) PT Lowered to $38 at Canaccord Genuity After Selling 7M Shares
June 8, 2017 11:33 AM EDTCanaccord Genuity lowered its price target on Exact Sciences (NASDAQ: EXAS) to $38.00 (from $40.00) while maintaining a Buy rating. EXAS announced a raise of 7M shares of common stock at $35/share, to add $245M in gross proceeds and raise its cash balance to ~$500M.... More
